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Cell proliferationpresenting the acute loss of shear stress (simulated ischemia) to ﬂow-adapted
pulmonary microvascular endothelial cells (PMVEC) leads to reactive oxygen species (ROS) generation that
signals for EC proliferation. We evaluated the role of caveolin-1 on this cellular response with mouse PMVEC
that were preconditioned for 72 h to laminar ﬂow at 5 dyn/cm2 followed by stop of ﬂow (“ischemia”).
Preconditioning resulted in a 2.7-fold increase in cellular expression of KATP (KIR 6.2) channels but no change
in expression level of caveolin-1, gp91phox, or MAP kinases. The initial response to ischemia in wild type cells
was cell membrane depolarization that was abolished by gene targeting of KIR 6.2. The subsequent response
was increased ROS production associated with activation of NADPH oxidase (NOX2) and then phosphoryla-
tion of MAP kinases (Erk, JNK). After 24 h of ischemia in wild type cells, the cell proliferation index increased
2.5 fold and the % of cells in S+G2/M phases increased 6-fold. This signaling cascade (cell membrane
depolarization, ROS production, MAP kinase activation and cell proliferation) was abrogated in caveolin-1
null PMVEC or by treatment of wild type cells with ﬁlipin. These studies indicate that caveolin-1 functions as
a shear sensor in ﬂow-adapted EC resulting in ROS-mediated cell signaling and endothelial cell proliferation
following the abrupt reduction in ﬂow.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
We have shown, initially with studies of the isolated perfused lung
and subsequently with endothelial cells in vitro, that acute cessation
of pulmonary perfusion results in increased production of reactive
oxygen species (ROS) by pulmonary endothelial cells as part of a
signaling cascade associated with altered mechanical stress [1–8]. The
loss of this response with deletion of gp91phox indicated that the
source of ROS is the endothelial cell NADPH oxidase and speciﬁcally
the isoform that is now called NOX2 [4,6,8]. One consequence of this
signaling cascade that was demonstrated with the in vitro model of
ischemia is ROS-mediated endothelial cell proliferation [5–7]. We
have postulated that this physiological event represents nascent an-
giogenesis to compensate for the loss of blood ﬂow. Recent studies
have suggested that caveolae in the cell membrane may respond to
alteredmechanotransduction [9–11] and led us to postulate that these
organelles could be a primary sensor for ischemia and for initiation of
subsequent cellular signaling events.EC, mouse pulmonary micro-
chloride; FITC, ﬂuorescein
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l rights reserved.The goals of the present study were to investigate the role of
caveolin-1 protein and caveolae in activation of ROS production and
microvascular cell proliferation associated with loss of shear stress
(ischemia). We evaluated microvascular endothelium in situ using both
the isolated perfused lung and an in vitro model of the pulmonary
microvascular endothelium. For the latter, pulmonary microvascular
endothelial cells in culture were pre-adapted to shear stress thereby
simulating their in situ physiological state. These studies have relevance
for understanding the endothelial cell response to acute ischemia and
the basis for altered mechanotransduction such as might be associated
with a pulmonary embolism, lung transplantation, or other pathologies
that result in abrupt cessation of pulmonary perfusion.
2. Materials and methods
2.1. Materials and animals
Fluorescent probes were 2′,7′-dichloroﬂuorescein (H2DCF) diacetate (Kodak, Ro-
chester, NY), bis-oxonol, Dil-acetylated low density lipoprotein (Dil-AcLDL), Alexa Fluor
488 AcLDL and amplex red/horseradish peroxidase (Molecular Probes, Eugene, OR).
Inhibitors and agonists used were thrombin, Na3VO4, okadaic acid and ﬁlipin (Sigma, St.
Louis, MO), cyclosporine A (Alexis, San Diego, CA), and nocodazole, 2-(2-amino-3-
methoxyphenyl)-4H-1-benzopryan-4-one (PD98059) and 1,4-diamino-2,3-dicyano-
1,4-bis[2-aminophenylthio] butadiene (U0126) (Calbiochem, San Diego, CA). Antibodies
used were anti-CD31 conjugated with ﬂuorescein isothiocyanate (FITC) (Caltag,
Burlingame, CA); anti-Kir 6.2 polyclonal (Alomone, Jerusalem, Israel); anti-gp91phox
Fig. 1. ROS production with ischemia in the isolated mouse lung. A. Amplex red (ROS
sensitive dye visualized in the red channel) and Alexa AcLDL (an endothelial speciﬁc
marker in the green channel) ﬂuorescence were visualized in endothelial cells in intact
wild type and caveolin-1−/− lungs. Yellow indicates co-localization of the two
ﬂuorophores. Images were acquired during perfusion (control) and at 5 min after the
stop of ﬂow (ischemia). B. Time course of ROS production during ischemia by wild type
and caveolin-1 null mouse lungs. Zero time represents the stop of perfusion. Each point
represents the average of 3–4 measurements in a lung ﬁeld. The results for ﬂuorescence
are in arbitrary units (au) and represent the mean±SE for n=3 separate lungs. ⁎pb0.05
vs. wild type.
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VE cadherin (BD Biosciences, Pharmingen); anti-ERK1/2, anti-p-ERK1/2, anti-JNK1/2,
anti-p-JNK1/2 and anti-caveolin-1 monoclonal (Santa Cruz Biotechnology, Santa Cruz,
CA); and anti-Factor VIII (Accurate Chem, Westbury, NY).
C57Bl/6 (wild type), caveolin-1−/− (stock #4585), and gp91phox−/− (stock #2365)
mice were obtained from the Jackson Laboratory (Bar Harbor, ME); Kir6.2−/− mice were
bred in our facility from breeding pairs supplied by Dr. S. Seino (Chiba University, Chiba,
Japan). The gp91phox and KIR 6.2 null mice are on the C57Bl/6 background. The caveolin-1
nullmiceare onamixedbackground (C57Bl/6,129/SvandSJL). These lattermicehavebeen
shown to lack plasmalemmal caveolae in endothelial cells [12]. All procedures involving
the use of mice were approved by the Institutional Animal Care and Use Committee.
2.2. Imaging of the isolated perfused lung
Imaging of the isolated perfused lungwas carried out withminormodiﬁcations of the
procedure as described previously [3]. Mice were anesthetized with 50 mg/kg intra-
peritoneal sodium pentobarbital and continuously ventilated through a tracheal cannula
with 5% CO2 in air (BOC group Inc. Murray Hill, NJ, USA). The chest was opened and the
pulmonary circulationwas cleared of blood by gravity ﬂow of perfusion through a cannula
inserted in the main pulmonary artery, exiting from the transected left ventricle. The
perfusatewasKrebs–Ringer bicarbonate solution (KRB:NaCl 118.45, KCl 4.74,MgSO47H2O
1.17, KH2PO4 1.18 and NaHCO3 24.87 mM) supplemented with 10 mM glucose and 5%
dextran to maintain osmolarity. The lung preparation was placed onto a chamber on the
stage of a two-photon scanning microscope (BioRad radiance 2000 confocal microscope,
Hercules, CA,with a coherentminor 900 high sapphire laser pump) for in situ imaging. The
microscope was equipped with an optical ﬁlter changer (lambda 10-2; Sutter Instrument
Co. Novato, CA), a Nikon Eclipse TE-300 digital camera (Melville, NY) and LaserSharp 2000
image acquisition software (BioRad, Hercules, CA). The Ti-sapphire source of the two-
photon system is a laser that produces photon pulses at femtosecond intervals. The laser
beam allows for penetration up to 150–200 μmbelow the lung surface at thewavelengths
used for measurement of amplex red and Alexa AcLDL.
Foroutlining the endothelium, the isolatedperfused lungwaspre-perfusedwithAlexa
AcLDL (1µg/ml) for 30min to allow for the uptake of theﬂuorophore, and the intravascular
dye was removed by 10 min perfusion with dye free buffer. For imaging ROS, lungs were
pre-perfused with amplex red (25 µM) plus horseradish peroxidase (25 µg/ml) in order to
detect H2O2 in the intravascular space. Perfusion into the pulmonary artery in the
preparation was maintained by a peristaltic pump generally at a ﬂow rate of 2 ml/min.
Ischemia was simulated by stop of perfusate ﬂow and endothelium was imaged for the
subsequent 5 min. Ventilation was maintained throughout the experiment and stopped
only at the point of image capture. For each experiment, scanning was focused on those
vessels which could be best visualized due to their optimal location. For each mouse, 3–4
ﬁelds were selected randomly for ﬂuorescence quantiﬁcation.
2.3. Cell isolation and cell culture
Pulmonary microvascular endothelial cells (MPMVEC) were isolated from lungs as
described previously [6,13,14]. Brieﬂy, freshly harvested mouse lungs were treated with
collagenase followed by isolation of cells by adherence to magnetic beads (Dynabeads,
Dynal, Oslo, Norway) coated with mAb (anti-CD31) to platelet endothelial cell adhesion
molecule (PECAM). MPMVEC were propagated in Dulbecco's modiﬁed Eagle medium
(DMEM) supplementedwith 10% fetal bovine serum (FBS), non-essential amino acids, and
penicillin/streptomycin and maintained under static culture conditions. The endothelial
phenotype of the preparationwas routinely conﬁrmedbyevaluating cellular uptake of DiI-
AcLDL and by immunostaining for PECAM (CD31), VE-cadherin, von Willebrand factor
(factor VIII), caveolin-1, and vascular endothelial growth factor (VEGF) receptor-1 (ﬂt1) and
-2 (ﬂk1). Cells were evaluated by both ﬂuorescence microscopy and ﬂow cytometry using
the FACSCalibur as described below. A549 cells from American Type Culture Collection
(Manassas, VA) were used as a negative control for immunostaining.
2.4. Flow adaptation and simulated ischemia
Cells were ﬂow-adapted during culture in an artiﬁcial capillary system using
previously described methods [5–7,14]. MPMVEC between passages 5–14 were seeded
at a conﬂuent density (14–18×106 cells per cartridge) and allowed 24 h for attachment.
Cells then were cultured under ﬂow of culture medium (Dulbeccos's modiﬁed Eagle
medium, DMEM) using commercially available artiﬁcial capillary technology (FiberCell
Systems, Frederick, MD). Flow adaptation in cartridges generally was carried out for
72 h at 5 dyn/cm2 shear stress. The nominal times indicated in this report do not include
the initial 24 h attachment period used for all experiments. For ﬂuorescence imaging
studies, the ﬂuorophore was added to the perfusate during the ﬁnal 1 h of the ﬂow-
adaptation period. Cells thenwere subjected to either 1 h of additional continuous ﬂow
(control) or 1 h of simulated ischemia. The perfusate during the loading and expe-
rimental periods was changed from DMEM to Krebs–Ringer bicarbonate (KRB) solution,
pH7.4, supplemented with 10 mM glucose, 25 mM HEPES, and 3% dextran. “Ischemia”
was simulated by rerouting the ﬂow from the luminal to the abluminal compartment.
This protocol eliminated shear stress but allowed continued oxygenation and substrate
delivery. For studies of cell proliferation, cells were grown under either ﬂow or static
conditions for 96 h while cells for study of ischemia were grown under ﬂow for 72 h
followed by 24 h of no ﬂow. Cells were removed from the cartridges by treatment with
0.25% trypsin or Accutase® (Chemicon International, Temecula, CA) for 5–10 min, andpelleted by centrifugation at 1400 ×g at 4 °C for 5 min. Cells were analyzed by ﬂow
cytometry, Western blot, and confocal microscopy.
2.5. Membrane depolarization with ischemia
Membrane depolarization was detected by live cell imaging using a cell membrane
potential probe [15,16]. MPMVEC in Dulbecco's modiﬁed Eagle mediumwere plated on a
glass slide (44×20 mm) that had been coated with 0.2% gelatin. When cells were fully
conﬂuent, the slidewas placed in a laminar ﬂow chamber (Confocal Imaging chamber RC-
30,Warner Instruments, Hamden, CT) andmaintained under static or continuous laminar
ﬂow (5 dyn/cm2) at 37 °C for 24 h. For experimental measurements, the growth medium
was substituted with supplemented Krebs–Ringer bicarbonate buffer. Cells in the ﬂow
chamber were perfused with the membrane potential-sensitive ﬂuorophore bis-oxonol
(200 nM) for 30 min and imaged before and after ﬂow cessation. Excitation for
ﬂuorescence imaging was accomplished with a Kr/Ar ion laser source at 488 nm and
imaged by confocal microscopy (Radiance, 2000, BioRad, Hercules, CA). For quantitation,
areas of interestwere randomly selected, and ﬂuorescence intensity of eachwasmeasured
and normalized as a percent change in intensity level from baseline. Endothelial
depolarization by incubation with medium containing 24 mM KCl was used to provide a
positive control; the Na+ concentration in high K+ solutions was adjusted to maintain
isomolarity.
2.6. ROS generation with ischemia
ROS generation was assessed by both ﬂuorescence imaging and ﬂow cytometry as
described previously [5–7,14]. Cells were pre-loaded in the ﬂow cartridges with 10 µM
H2DCF and its conversion to ﬂuorescent dichloroﬂuorescein (DCF) was measured.
H2DCF was used as the diacetate to promote cell entry. This compound is de-esteriﬁed
intracellularly to generate the free probe. DCF ﬂuorescence of the harvested cells was
evaluated by confocal microscopy (Radiance 2000, BioRad, Hercules, CA) at 530 nm
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using ImagePro software (Media Cybernetics, Silver Spring, MD). DCF ﬂuorescence also
was evaluated by ﬂow cytometry using a 4-color, dual laser FACSCalibur (Becton
Dickinson, San Jose, CA). Excitation was by a 488 nm argon laser and light was collected
using a 530±15 nm bandpass ﬁlter [5].
2.7. Cell proliferation and cell cycle analysis
Cell proliferation was studied by labeling endothelial cells with PKH26, a lipid
soluble dye that localizes in cell membranes, and analyzed by ﬂow cytometry as de-
scribed previously [5,17]. Cells showed N95% labeling efﬁciency. All events were plotted
in a CD31-FITC vs. side scatter plot (SSC-H) and a gate was set around the CD31 positive
cells to capture the endothelial cell population [5]. Compensation for PKH26 was
concentration dependent and was determined empirically. Quantitative analysis of cell
proliferation was performed by collecting 5×104 events and calculated using
CellQuest™ acquisition/analysis software (Becton Dickinson) and the Proliferation
Wizard™ module of the ModFit LT™ Macintosh program (Verity Software House,
Topsham, Maine).
For cell cycle analysis, PMVEC (1×106) were pelleted and incubated with RNAase
(100 µg/ml) and propidium iodide (4 µg/ml) in Tris buffer (pH7.6) with Nonidet P40
(0.2%) at 4 °C. Cell cycle phases were analyzed by ﬂowcytometry and the percent of cells
in each phase of the cell cycle was calculated based on cellular DNA content using theFig. 2. Phenotype of pulmonary microvascular endothelial cells. A. Images of endotheli
immunoﬂuorescence (non-permeabilized cells) with anti-CD31 (PECAM-1), anti-vWF, and a
with anti-VE-cadherin, anti-Flk-1 and anti Flt-1 mAbs. The scale bars indicate 50 µm for Flt
shown in A. a, caveolin-1 null cells; b, wild type cells; c, wild type cells without primary a
membrane for gp91phox (58 kDa) and cell lysates for Kir6.2 (37 kDa) and caveolin-1 (22 kDa)
actin was used as a loading control.ModFit program. The tetraploid and aneuploid populations, as deﬁned by their ab-
normal content of DNA, were excluded from the calculations.
2.8. Western blot analysis
Western blotting utilized the two-color Odyssey™ LI-COR (Lincoln, NE) technique
as previously described [17]. Quantitation of bands is based on measurement of
ﬂuorescence. Secondary dual-labeled antibodies were IrDye 800™ goat anti-rabbit
(Rockland, Gilberstville, PA for the green 800 nm channel) and Cy5.5 or Alexa 680 goat
anti-mouse (Molecular Probes, Eugene, OR, for the red 700 nm channel). For protein
assay, cell pellets were resuspended in a solution of 50 mM potassium phosphate,
0.1 mM EDTA, and 0.1% 3-[(3-chloramidopropyl)dimethylammonio]-1-propansulfonate
buffer (pH 7.0). The cells were sonicated on ice using a probe sonicator by two bursts of
15 s each with a 110 s interval at 40% of maximum output. Cell sonicate protein
concentration was determined by Coomassie blue assay (BioRad, Richmond, CA) with
bovine IgG as the standard.
2.9. Statistics
Results are expressed as the mean±SE for three or more independent experiments.
Signiﬁcance was determined by ANOVA or t test as appropriate using SigmaStat (Jandel
Scientiﬁc, San Jose, CA), and the level of statistical signiﬁcance was deﬁned as Pb0.05.al cells from wild type and caveolin-1−/− mice with ﬂuorescent DiI-AcLDL, surface
nti-caveolin-1 mAbs, and intracellular immunoﬂuorescence cells (permeabilized cells)
-1 and caveolin-1 and 20 µm for the others. B. Flow cytometry histograms for markers
ntibody (IgG control); d, unstained wild type cells. C. Western blot of isolated plasma
protein expression in wild type (WT), KIR 6.2−/−, gp91phox−/−, and caveolin-1−/− cells. β-
Fig. 3. Response of mouse pulmonary microvascular endothelial cells in vitro to varying
duration and magnitude of laminar shear stress. Cells were ﬂow-adapted in cartridges
and then subjected to 1 h of ischemia for measurement of ROS production by DCF
ﬂuorescence or 24 h of ischemia for measurement of cell proliferation using ﬂow
cytometry. Results are mean±SE for n=4. ⁎pb0.05 for the preceding value on the curve.
A. ROS production and B. cell proliferation as a function of time of exposure to 5 dyn/
cm2 shear stress. C. ROS production and D. cell proliferation as a function of shear stress
following 72 h of exposure to ﬂow.
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3.1. ROS production by endothelium in situ
Consistent with our previous studies [3], imaging of the isolated
lung fromwild type mice showed increase of amplex red ﬂuorescence
with ischemia indicating the generation of ROS (Fig. 1A). The red dye
marker for ROS showed co-localization with Alexa acetylated LDL, a
green marker for endothelium, as indicated by the yellow color in the
overlay panel (Fig. 1A). The increase in endothelial ﬂuorescence
with ischemia was time-dependent and reached an apparent plateau
at ~4–5 min (Fig. 1B). Increased endothelial ﬂuorescence with
ischemia was not observed in the caveolin-1 null mouse lungs
(Fig. 1A, B). Further studies to demonstrate the mechanism for the
loss of response to ischemia were carried out using our ischemia
models with isolated cells.
3.2. Phenotype of MPMVEC
The endothelial phenotype of isolated endothelial cells was eval-
uated by immunohistochemical analysis and ﬂow cytometry expres-
sion of CD31, VE-cadherin, factor VIII, ﬂt-1, ﬂk-1 and uptake of Dil-Ac-
LDL by immunoﬂuorescence. Both wild type and caveolin-1−/− cells
were positive for all 5 antigens and demonstrated uptake of DiI-Ac-
LDL, conﬁrming the endothelial phenotype (Fig. 2A, B). The endothe-
lial phenotype for our preparations of gp91phox−/− and KIR 6.2−/−
pulmonary microvascular endothelial cells has been demonstrated
previously [17] and results were conﬁrmed in the present study (not
shown). Caveolin-1 expression was detected in wild type endothelial
cells by immunohistochemistry (Fig. 2A) and Western blot (22 kDa,
Fig. 2C) but was absent in caveolin-1−/− cells. Western blot conﬁrmed
the presence of caveolin-1 and absence of gp91phox (58 kDa) in the
gp91phox null cells and of KIR 6.2 (37 kDa) in the KIR 6.2 null cells
(Fig. 2C).
3.3. Parameters for ﬂow adaptation
In order to determine the optimal parameters for ﬂow adap-
tation, cells in the cartridges were subjected to 5 dyn/cm2 shear stress
for 24–72 h or varying shear stress (1–10 dyn/cm2) for 72 h. Mea-
surement of ROS production (by DCF ﬂuorescence) or cell proliferation
(by PKH26) using FACS analysis for both showed essentially maximal
response at 5 dyn/cm2 for 72 h (Fig. 3) and this regimen was used for
subsequent studies. This response for ROS production for mouse
pulmonary microvascular cells indicated a slightly longer duration of
ﬂow exposure and higher shear stress for maximal effect as compared
to our previous studies with bovine pulmonary artery endothelial cells
[7]. Western blot analysis of ﬂow-adapted vs. cells cultured under
static conditions showed a 3.1-fold increase in KIR 6.2 expression
(Table 1) as we have demonstrated previously using rat pulmonary
microvascular endothelial cells [18]. The KIR 6.2 expression level
increased only 1.4-fold (not statistically signiﬁcant) in caveolin-1 null
cells with this ﬂow-adaptation protocol (not shown). The expression
levels of caveolin-1, gp91phox, Erk 1/2 and JNK 1/2 did not change with
ﬂow adaptation of wild type cells (Table 1) or caveolin-1 null cells (not
shown).
3.4. Endothelial cell membrane potential during ischemia
Based on our previous observations [3,13,15,19,20], we investigated
the change in cell membrane potential of MPMVEC with ischemia
using bis-oxonol as the reporter ﬂuorophore. Consistent with our
previous results, ﬂow-adaptedwild typeMPMVEC showed an increase
in bis-oxonol ﬂuorescence after ﬂow cessation compatible with
membrane depolarization (Fig. 4). The change in bis-oxonol ﬂuores-
cence with ischemia was attenuated in KIR 6.2 null cells as shownpreviously [15,19] and was essentially absent in caveolin-1 null
MPMVEC (Fig. 4). To evaluate whether these populations of null cells
could manifest a change in membrane potential with an appropriate
stimulus, MPMVEC cultured under static conditions were incubated
with a solution containing a high concentration of KCl (24 mM). An
increase in bis-oxonol ﬂuorescence was observed for both wild type
and caveolin-1 null MPMVEC but the response in KIR 6.2 null MPMVEC
was greatly attenuated (Fig. 4). In contrast to the response to ischemia,
the increase in bis-oxonol ﬂuorescence in the presence of KCl was
similar for wild type and caveolin-1 MPMVEC (Fig. 4). These results
indicate that caveolae are required for the cell membrane depolariza-
tion response to ischemia.
3.5. ROS production with ischemia by MPMVEC in vitro
Oxidation of H2DCF to ﬂuorescent DCF was used to evaluate
cellular generation of ROS in the isolated cell model. H2DCF was used
instead of amplex red as the latter is an extracellular ﬂuorophore. DCF
ﬂuorescence by confocal microscopy was at a relatively low level in
MPMVEC studied during ﬂow (with a brief, ~5 min, ischemic period
required for removal of cells from the cartridges), but increased
markedly during 1 h ischemia as detected by confocal microscopy and
ﬂow cytometry (Fig. 5A, B and C). By contrast, there was no DCF
oxidation with ischemia in caveolin-1−/− MPMVEC (Fig. 5A, B, C)
consistent with the results obtained with the intact isolated lung
(Fig. 1). ROS production with ischemia also was not seen in MPMVEC
that were pretreated with ﬁlipin (Fig. 5A, B, C), a membrane-
impermeable cholesterol-binding drug that results in disruption of
caveoli.
We evaluated the effect of thrombin on DCF oxidation to conﬁrm
that caveolin-1−/− cells do possess an intact NADPH oxidase and
that loss of oxidase expression did not account for the failure to
produce ROS with ischemia. Wild type MPMVEC showed ROS
generation when stimulated with thrombin (Fig. 5D), an agent
Table 1
Ratio of the expression levels of protein vs. β-actin by Western blot in static and ﬂow-
adapted mouse pulmonary microvascular endothelial cells
Ratio Static Flow 72 h
Caveolin-1 1.2±0.2 1.2±0.2
gp91phox 1.0±0.2 0.9±01.
KIR 6.2 1.0±0.2 3.1±0.3⁎
ERK 1/2 1.0±0.2 1.0±0.2
JNK 1/2 1.0±0.2 1.0±0.2
MPMVEC were cultured under 5 dyn/cm2 shear stress for 72 h. Values are mean±SE for
n=4. ⁎Pb0.05 vs. static.
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not respond, compatible with absence of the ﬂavoprotein compo-
nent of NADPH oxidase (Fig. 5D). Treatment of caveolin−/−MPMVEC
with thrombin led to a similar increase of DCF ﬂuorescence as in
wild type cells indicating that they are capable of generating ROS
via NADPH oxidase (Fig. 5D). These results indicate that caveolin-1
is “upstream” from NADPH oxidase activation during the response
to ischemia.Fig. 4.Membrane depolarization detected by bis-oxonol ﬂuorescence. A. Confocal microscop
adapted cells were evaluated with continuous ﬂow (control) or 1 h ischemia. Cells cultured u
Cell membrane depolarization is indicated by increased ﬂuorescence. The scale bars indica
experiments described in A. au=arbitrary units. ⁎Pb0.05 vs. the corresponding control.3.6. Phosphorylation of MAP kinases with simulated ischemia
As our studies suggest that signaling through caveolin-1 occurs
with ﬂow cessation, we evaluated possible activation of MAP kinases
under these conditions using speciﬁc antibodies. We previously have
demonstrated in bovine pulmonary artery endothelial cells that
ischemia results in phosphorylation of ERK 1/2 [14]. In the present
study, ischemia for 15 min resulted in a 4-fold increase in
phosphorylation level of Erk as well as JNK (Fig. 6A, B). There was
no change in the phosphorylation level of p38 associated with
ischemia (data not shown). The increased phosphorylation of Erk/JNK
was markedly diminished in gp91phox−/− cells (Fig. 6A, B), indicating
that ROS generation with ischemia is required for activation of the
MAP kinases in MPMVEC as previously shown for bovine cells [14].
The speciﬁc inhibitors, PD98059 for Erk and U0126 for JNK, markedly
depressed ischemia-mediated phosphorylation of the target kinases
(Fig. 6C, D). Okadaic acid and cyclosporin A treatment resulted in
increased Erk and JNK phosphorylation, presumably due to inhibition
of phosphatases while orthovanadate had no effect (Fig. 6C, D). This
result suggests speciﬁcity of phosphatases in these cells towards
phosphorylated MAP kinases. Erk/JNK phosphorylation with ischemiay of wild type, caveolin-1−/− and KIR 6.2−/− cells loaded with bis-oxonol (200nM). Flow-
nder static conditions were evaluated before (control) and after addition of 24 mM KCl.
te 20 µm. B. Bis-oxonol ﬂuorescence intensity showing the mean±SE for n=4 for the
Fig. 5. ROS generation in ischemia as indicated by DCF ﬂuorescence. A. Confocal microscopy of ﬂow-adapted wild type (WT) MPMVEC immediately upon cessation of ﬂow (left panel)
followed by 1 h of ischemia for WT cells (panel 2), wild type cells pretreated with ﬁlipin (1μg/ml) (panel 3), or caveolin-1−/− cells (right panel). The scale bar indicates 10 µm. B. DCF
ﬂuorescence (mean±SE, n=4) for experiments shown in A. ⁎Pb0.05 vs.WT, ischemia. C. Flow cytometric analysis of ROS production (DCF-labeled cells) with ischemia forwild type plus or
minus ﬁlipin and caveolin-1 null. D. The effect of thrombin on ROS production by wild type, caveolin-1−/−, Kir6.2−/− and gp91phox−/−MPMVEC cells cultured under static conditions and
evaluated by ﬂow cytometry. DCF-labeled cells were stimulated with thrombin (1 U) for 30 min (a) and compared to unstimulated cells labeled with DCF (b) and non-labeled cells (c).
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pretreated with ﬁlipin (Fig. 6C,D) and levels in the null cells were
unchanged by the phosphatase inhibitors (not shown).
3.7. Cellular proliferation and cell cycle with simulated ischemia
Proliferation of MPMVEC seeded at a sub-conﬂuent density (1×106
per cartridge)wasevaluated after culture for 96hunder static conditions
or with continuous laminar ﬂow (5 dyn/cm2). The proliferation index
(PI) of cells at day 0 was set to 1.0. As previously shown [5,6], the
ﬂuorescence distribution of wild type MPMVEC cultured in cartridges
under static conditions demonstrated multiple peaks indicating several
generations of cell division (not shown). On the other hand, the
ﬂuorescence distribution for cells cultured for 96 h underﬂow showed a
single peak (Fig. 7A) indicating a lack of cell division. These results are
compatible with ﬂow-mediated inhibition of cell division as observed
previously [5,6,22]. The proliferation index of wild type MPMVEC
signiﬁcantly increased with ischemia (Fig. 7A). Proliferation was
markedly attenuated with ﬁlipin pretreatment (Fig. 7A). The prolifera-
tive responsewith ischemia alsowasmarkedly attenuated in caveolin-1null cells (Fig. 7A). These results indicate a requirement for ROS in order
to initiate cell proliferation following ischemia as shown by our previous
studies [5,6]. The MAP kinase inhibitors PD98059 and U0126 signiﬁ-
cantly attenuated cell proliferation (Fig. 7B). Treatment of wild type cells
with the phosphatase inhibitors okadaic acid and cyclosporine A
signiﬁcantly increased proliferation (Fig. 7B) suggesting that protein
phosphorylation is important in the signaling cascade. Vanadate had no
effect (Fig. 7B). This response to phosphatase inhibitors shows the same
pattern as seen for MAP kinase phosphorylation (Fig. 6C, D). The PI with
ischemia did not increase in the caveolin-1 null cells even in the
presence of phosphatase inhibitors (Fig. 7B).
The yield of cells obtained by trypsinization from the cartridges
was used as another index of cell proliferation. There was a marked
increase in the cell yield in ischemia compared with continuous ﬂow
(Fig. 7C). This response was inhibited with ﬁlipin pretreatment and
abrogated by caveolin-1 knock-out (Fig. 7C). These results conﬁrm
those obtained with the ﬂow cytometry method.
Cell cycle analysis of wild type ﬂow-adapted MPMVEC during
continuous ﬂow showed fewer than 10% of cells in the S+G2/M phases;
with the observed ischemia, the % of cells in S+G2/M increased to 35%
Fig. 6. Phosphorylation of MAP kinases in wild type (WT) and mutant MPMVEC with ischemia (A, B) and the effect of inhibitors (C, D). Cells were ﬂow-adapted for 72 h in the
cartridges and ﬁxed during ﬂow or at 15 min after cessation of ﬂow. Cells were collected after trypsinization from the cartridges and phosphorylation of Erk1/2 and JNK1/2 was
detected by staining of permeabilized cells. Results are quantiﬁed as the ﬂuorescence ratio for phosphorylated vs. total protein. Values aremean±SE for n=4. The effect of ischemia on
phosphorylation of Erk 1/2 (A) and JNK 1/2 (B) is shown for wild type (WT), gp91phox null and caveolin-1 null MPMVEC. ⁎pb0.05 vs. ﬂow. The effect of phosphatase/kinase inhibitors
and ﬁlipin on phosphorylation of Erk 1/2 (C) and JNK 1/2 (D) during ischemia in ﬂow-adapted wild type cells. Results are presented as a % of the corresponding ischemia value shown
in A and B. Filipin (1 µg/ml); OA, okadaic acid (100nM); CyA, cyclosporine A (100 nM); Van, Na3VO4 (100 nM); PD98059 (50 µM); and U0126 (10 µM). ⁎pb0.05 vs. no inhibitors.
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proliferation. Caveolin-1 null cells showedahighpercentage in theG2/M
phase in both conﬂuent (Fig. 8) and sub-conﬂuent (not shown) pop-
ulations with no signiﬁcant change in cell cycle distribution in response
to ischemia (Table 2).
To further evaluate the effect of caveolin-1 knock-out, we treated
sub-conﬂuent cells for 12 h with nocodazole, an agent known to cause
disruption ofmicrotubules andG2/M arrest.Wild type and gp91phox−/−
MPMVEC showed an increase in the percent of cells in the G2/Mphases
reﬂecting G2M arrest while the percent of caveolin null cells in G2/M
was unchanged (data not shown). These results are compatible with a
relative cell cycle arrest for proliferating caveolin-1 null cells.
4. Discussion
The present study conﬁrms our previous results which showed
that abrupt cessation of shear in intact lungs or to ﬂow-adapted
endothelial cells results in the production of ROS [1–8]. Knock-out of
gp91phox results in loss of ROS generation with ischemia indicating
that NOX2 is the responsible oxidase [4,6,8,19]. This effect appears to
be initiated by endothelial cell membrane depolarization and knock-
out of the KATP channel (KIR 6.2 null cells) attenuates membrane
depolarization, although other channels may maintain a partial re-sponse. The depolarization response also is abolished by KATP channel
agonists such as cromakalim andwe have postulated that these agents
prevent channel closure with ischemia [3,15,19]. KATP knock-out or
treatment with cromakalim abrogates ROS generation indicating that
cell membrane depolarization precedes activation of the NADPH
oxidase. Finally, cell proliferation is subsequent to ROS generation and
is prevented by manipulations that alter activation of the oxidase.
The use of ROS scavengers indicates that the major signaling
oxidant during ischemia is H2O2 since the effect is abolished by the
presence of catalase but is relatively unaffected by SOD. However, the
initiating oxidant is the superoxide anion which is produced by NOX2
and is then dismutated to H2O2. NOX2 produces O2U− on the extra-
cellular side of the cell membrane but the H2O2 product can rapidly
transverse the cell membrane for intracellular signaling. These path-
ways for the signaling response to ischemia are shown schematically
in Fig. 9.
The major goal of the present study was to determine the role
of caveolae in the endothelial response to abrupt reduction of shear
stress. Caveolae previously have been described as an endothelial cell
shear sensor in models of increased shear [9–11,23,24]. The impaired
response to increased shear was corroborated in the present study by
the failure of KIR induction during the ﬂow-adaptation period in
caveolin-1 null cells. The role of caveolae in ischemia (decreased shear)
Fig. 7. Effect of ischemia on the proliferation of ﬂow-adapted wild type (WT) and caveolin-1−/− mouse pulmonary microvascular endothelial cells (MPMVEC). A. Analysis by ﬂow
cytometry of PKH26 labeled wild type and caveolin-1 null MPMVEC that were studied during ﬂow and after 24 h of ischemia. Where indicated, ﬁlipin (1 μg/ml) was added during the
last 30min of ﬂow-adaptation. Cell proliferationwas determined by PKH26 ﬂuorescence intensity of the CD31-positive population usingModFit software. The proliferation index (PI)
is indicated in each panel. The PI of caveolin-1 null cells grown under static conditions is shown as a control. B. The effect of phosphatase, protein kinase, andMAP kinase inhibitors on
cell proliferation of wild type MPMVEC subjected to 24 h ischemia. The inhibitors were added during the last hour of ﬂow adaptation. The concentrations of inhibitors were the same
as shown in Fig. 6. Control is ischemia in the absence of inhibitors. Values are mean±SE for n=4. ⁎pb0.05 vs. the untreated cells. C. The % increase in yields (ischemia vs. continuous
ﬂow) of cells trypsinized from the cartridges (mean±SE, n=5) for conditions shown in A.
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out of caveolin-1, the major cytoskeletal protein of caveolae, and by
treatment of cells with ﬁlipin, a cholesterol trapping reagent that
disrupts caveolar function. Knock-out of caveolin-1 abrogated the
responses to acute cessation of ﬂow; there was essentially no de-
polarization of the cell membrane (Fig. 4), no ROS generation (Fig. 5),
and no cell proliferation (Figs. 7 and 8). Less extensive studies with
ﬁlipin showed similar effects. Studies of isolated perfused lungs from
caveolin-1 null mice (Fig. 1) corroborated the results with the cell
culture system.Wild type and caveolin-1 null cells had similar increase
of ROS production in response to thrombin, an agent that does notrequire caveolae for activation of NADPH oxidase. This result indicates
that the activation machinery for the oxidase is present in caveolin-1
null cells. Since the oxidase is not activated by loss of shear in these
cells, they appear to have speciﬁcally lost the ability to respond to
mechanotransduction. As this and our previous studies show, activa-
tion of NADPH oxidase with ischemia requires preceding endothelial
cell membrane depolarization [3,5,6,8,15]. The failure of caveolin-1
null cells to depolarize with ischemia may reﬂect in part their sig-
niﬁcantly lower level of KIR 6.2 compared to wild type in the ﬂow-
adapted cells; thus, it is not possible to determine in the caveolin-1 null
cells the relative roles of altered ﬂow sensing by caveolae vs. altered
Fig. 8. Analysis of cell cycle for wild type and caveolin-1−/−MPMVEC in response to ischemia. A. Endothelial cells were cultured for 72 h under ﬂow followed by 24 h of continued ﬂow
or 24 h ischemia. Cartridges were seeded with 18.0×106 cells to promote conﬂuence. The distribution of diploid cells in G1/G0, S, and G2/M phases was evaluated by ﬂow cytometry
analysis.
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the other hand, abrogation of the ischemic response by pretreatment
with ﬁlipin provides evidence that functional caveolae are indeed
necessary. Coupling between caveolae and activation of NADPH oxi-
dase has been demonstrated for other stimuli, including endothelin-1
in HUVEC [25] and angiotensin II in vascular smooth muscle cells
[26,27]. Whether these responses also require depolarization of the
plasma membrane is not known.
Abrupt reduction of shear resulted in phosphorylation of MAP
kinases, speciﬁcally Erk and JNK, which required the presence of
caveolae as it was abolished by caveolin-1 knock-out. Phosphorylation
of Erk/JNK with ischemia was not observed in NOX2 null cells (Fig. 6)
and was depressed in the presence of ROS inhibitors/scavengers [14].
Thus, the signaling pathway leading to ERK/JNK activation appears to
require activation of NOX2 with ROS production. Recent studies
indicate a role for Ras in ROS-mediated ERK 1/2 activation [28,29] andTable 2
Distribution of cell cycle phases (%) by ﬂow cytometry in ﬂow-adapted mouse
pulmonary microvascular endothelial cells during continuous ﬂow and during ischemia
G0/G1 S G2/M
Flow
Wild type 95.11±2.25 2.98±0.64 0.96±0.25
Caveolin-1 null 53.03±1.43⁎ 2.44±0.81⁎ 43.92±3.02⁎
Ischemia
Wild type 60.03±4.87 16.43±5.16 24.26±4.05
Caveolin-1 null 47.04±3.03⁎ 3.56±1.65⁎ 47.92±3.17⁎
Cells were cultured under 5 dyn/cm2 shear stress for 72 h followed by 24 h of ischemia
or 24 h of continued ﬂow. Values are mean±SE for the % of cells in each cell cycle phase
(n=4). ⁎pb0.05 vs. the corresponding wild type.
Fig. 9. Scheme for the cell signaling response to ischemia. Altered shear stress is
“sensed” by caveolae resulting in KATP channel closure and cell membrane depolariza-
tion. Subsequent activation of NADPH oxidase (NOX2) and downstream signaling
pathways results in cell proliferation which may be a compensatory mechanism to
restore perfusion.
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cyclic strain in endothelial cells [30]. Lipid rich domains such as those
comprising caveolae and lipid rafts have been proposed as redox
signaling platforms where NADPH subunits and related proteins
cluster in response to various stimuli [31]. We propose that the
caveolar-associated mechanotransduction platform that is formed in
association with the altered shear stress of abrupt ischemia includes
the KATP channel proteins in addition to NOX2-associated proteins and
MAP kinases or other signaling proteins.
The present results conﬁrm our previous studies showing that
endothelial cells in vitro proliferate in response to simulated ischemia
[5,6]. The cell proliferative response required their prior ﬂow adap-
tation with maximal response in cells adapted to 5 dyn/cm2 shear
stress for 72 h. Themechanism for priming of this response to altered
ﬂowmay reﬂect increased expression of cellular mechanoresponsive
elements as both this and a previous study with rat pulmonary mic-
rovascular endothelial cells have demonstrated a signiﬁcant induc-
tion of KATP channels [18] during the ﬂow-adaptation period. Further,
long term exposure to shear stress in rat pulmonary microvascular
endothelial cells led to increased plasma membrane association of
caveolin-1 protein [9] although our studies with mouse endothelial
cells showed no change in total caveolin-1 expression during ﬂow
adaptation. Endothelial cells in situ should be ﬂow-adapted normally
as they are constantly exposed to shear. Cell proliferation with is-
chemia requires the signals associated with ROS since it is abolished
by inhibition of ROS generation, either through pharmacologicmeans
(cromakalim, DPI) or by molecular manipulation (KATP or gp91phox
knock-out). Generation of ROS with ischemia in vitro previously
was shown to result in increased DNA synthesis and cell proliferation
[5–7]. Indeed, ROS can mediate Ras-induced cell cycle progression
and mammalian cell proliferation and have been shown to stimulate
angiogenesis [22,32]. An alternative explanation for the present in
vitro results is that mechanical stress associated with ﬂow results in
depletion of cells from the artiﬁcial capillaries leading to loss of
“contact inhibition”, so that cell division resumes when the anti-
proliferative effect of shear stress is discontinued. This possibility for
the effect of ischemia is unlikely because sub-conﬂuent cells grown
under static conditions do not show inhibition of proliferationwith a
KATP channel agonist or an inhibitor of ROS production [5]. The
absence of ischemia-induced proliferation in the presence of cro-
makalim or DPI and in KATP channel or NOX2 null cells contrasts
sharply with the lack of effect of these agents on the proliferation of
sub-conﬂuent endothelial cells grown under static conditions [6].
Therefore, the mechanism for initiation of cell division appears to be
different for ischemia after ﬂow adaptation versus sub-conﬂuent
static cell cultures. We also demonstrated previously that prolifera-
tion with ischemia is not a response to endothelial cell death [6].
Exposure of endothelial cells to steady laminar ﬂow has been
shown previously and in the present results to decrease cellular pro-
liferation [22,33]. The increase of cells in the G0/G1 phase during
exposure to shear stress is accompanied by a reciprocal decrease in the
number of cells in the S and G2/M phases, indicating that steady
laminar shear blocks a cell cycle event prior to entry into the S phase.
Flow cessation (in ﬂow-adapted cells) results in the inverse effect,
namely entry of cells into the S phase and cellular proliferation. KIR 6.2
and gp91phox null cells showed a failure of entry into the cell cycle
with G1/G0 arrest [6]. Since caveolin-1 is a negative regulator of the
cell cycle [34], its knock-out might be expected to result in a prolife-
rative response, but these cells demonstrated G2/M arrest and abro-
gation of proliferation with ischemia. Thus, shear stress as sensed by
caveolae may play a key regulatory role in maintenance of the
endothelial cell population.
In summary, we have shown using an in vitromodel of oxygenated
“ischemia” that ﬂow-adapted endothelial cells sense the cessation of
ﬂow through a mechanism involving caveolae resulting in a signaling
cascade of cell membrane depolarization, NOX2 activation with in-creased ROS production, activation of MAP kinases (Erk 1/2, JNK) and
cellular proliferation. We postulate that this cell proliferative response
to altered shear stress represents an attempt at neovascularization in
order to restore blood ﬂow to the ischemic tissue.
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